druckenmiller-13f

13F disclosure

druckenmiller 13f

reported through filed loaded disclosed holdings 70

Reported allocations

Quarter-end holdings from the manager’s 13F. Weight is calculated from the disclosed equity book; it is not our simulated mirror allocation and it is not a live portfolio.

TSM Taiwan Semiconductor Manufac 23.07%
AA Alcoa Corp 13.65%
EWZ Ishares Inc 11.70%
RSP Invesco Exchange Traded Fd T 11.35%
TEVA Teva Pharmaceutical Inds Ltd 9.87%
EWZ Ishares Inc 9.51%
AVGO Broadcom Inc 8.36%
STM Stmicroelectronics N V 6.50%
SPY State Str Spdr S&P 500 Etf T 4.22%
LSCC Lattice Semiconductor Corp 4.13%
SNDK Sandisk Corp 3.34%
UAL United Airls Hldgs Inc 3.33%
TWLO Twilio Inc 3.15%
JBL Jabil Inc 3.01%
AMZN Amazon Com Inc 3.00%
SCCO Southern Copper Corp 2.89%
CLF Cleveland-Cliffs Inc New 2.69%
BE Bloom Energy Corp 2.55%
INTC Intel Corp 2.50%
PTGX Protagonist Therapeutics Inc 2.32%
U Unity Software Inc 2.23%
ARM Arm Holdings Plc 2.23%
NET Cloudflare Inc 1.49%
IWM Ishares Tr 1.41%
TWST Twist Bioscience Corp 1.35%
COHR Coherent Corp 1.33%
AMZN Amazon Com Inc 1.31%
CLS Celestica Inc 1.29%
MU Micron Technology Inc 1.09%
SATS Echostar Corp 0.98%
ALM Almonty Inds Inc 0.94%
LITE Lumentum Hldgs Inc 0.67%
NTRA Natera Inc 0.08%
INSM Insmed Inc 0.03%
SE Sea Ltd 0.01%
YPF Ypf Sociedad Anonima 0.01%
WWD Woodward Inc 0.01%
ROKU Roku Inc 0.01%
Unmapped Bbb Foods Inc 0.01%
Unmapped Newamsterdam Pharma Company 0.01%
CPNG Coupang Inc 0.01%
OPCH Option Care Health Inc 0.01%
FIGR Figure Technology Solutio 0.01%
CAI Caris Life Sciences Inc 0.00%
QSR Restaurant Brands Intl Inc 0.00%
RVMD Revolution Medicines Inc 0.00%
HUM Humana Inc 0.00%
WAB Wabtec 0.00%
Unmapped Crh Plc 0.00%
NUVB Nuvation Bio Inc 0.00%
ARGT Global X Fds 0.00%
OLMA Olema Pharmaceuticals Inc 0.00%
Q Qnity Electronics Inc 0.00%
ADMA Adma Biologics Inc 0.00%
XENE Xenon Pharmaceuticals Inc 0.00%
Unmapped Linde Plc 0.00%
DAKT Daktronics Inc 0.00%
GSG Ishares S&P Gsci Commodity- 0.00%
Unmapped Seagate Technology Hldngs Pl 0.00%
VIST Vista Energy S.A.B. De C.V. 0.00%
BLTE Belite Bio Inc Sponsored 0.00%
STUB Stubhub Hldgs Inc 0.00%
Unmapped Jbs N.V. 0.00%
Unmapped Lyondellbasell Industries Nv 0.00%
MELI Mercadolibre Inc 0.00%
PCT Purecycle Technologies Inc 0.00%
SOLS Solstice Advanced Matls Inc 0.00%
DBVT Dbv Technologies S A Sponsored 0.00%
WLK Westlake Corporation 0.00%
Unmapped Wave Life Sciences Ltd 0.00%

Open the SEC filing →

Druckenmiller 13F Playbook

Generated from LEDGER.json by ledger-stats · as of 2026-08-17 local. Do not hand-edit; prose narrates, this block is the record.

Ledger metric Value
Starting capital $100,000.00
Cash $55,757.93
Closed-trade record 10 closed · 4W / 6L
Realized P&L $307.12

Open positions

Ticker Shares Avg entry Cost
AA 140.8641 $68.36 $9,629.47
AMZN 0.844 $226.50 $191.17
ARM 15.0708 $149.11 $2,247.21
AVGO 26.8425 $314.55 $8,443.31
BE 7.3236 $98.69 $722.77
CLF 105.5357 $8.40 $886.50
CLS 4.4255 $294.84 $1,304.81
COHR 5.1898 $258.16 $1,339.80
INTC 50.1667 $50.38 $2,527.40
JBL 11.3215 $268.49 $3,039.71
LITE 0.8238 $826.88 $681.18
LSCC 14.9135 $78.65 $1,172.95
MU 3.0061 $366.09 $1,100.50
NET 7.1288 $211.69 $1,509.10
SCCO 2.6272 $146.80 $385.67
SNDK 4.8101 $701.59 $3,374.72
TWLO 24.3123 $130.95 $3,183.70
TWST 27.142 $50.21 $1,362.80
U 36.1714 $22.75 $822.90
UAL 7.2866 $113.01 $823.46

Who I Am (External Persona)

I am Stanley Druckenmiller via the Duquesne Family Office 13F filings. I don't talk in this system. I'm mirrored: every quarter, Duquesne files its 13F-HR, I diff it against the prior quarter, and replicate the changes here at scaled sizing.

This persona is not an internal voice. It is a signal source. What Druckenmiller rotates into and out of is the signal.

Mission Statement (as copy-trader)

Mirror Duquesne Family Office's quarterly 13F holdings in a $100K paper book. Duquesne is a family office, not a public hedge fund, so the 13F reflects Druckenmiller's personal capital — highest signal-to-noise of any tracked filer.

Methodology (Druckenmiller's, not ours)

  1. Concentrate and bet hard. "You shouldn't be in the business if you're not concentrating."
  2. Get the macro right first, then pick names. Stocks express a view on the cycle.
  3. Don't anchor. Cut losers, add to winners. "Never invest in the present."
  4. Liquid risk assets express macro views. Semis on AI capex, dollar on Fed cycles.
  5. Short when warranted. 13F doesn't show shorts — known blind spot.
  6. Rotate ruthlessly. High turnover by buy-and-hold standards.
  7. Never lose big. Capital preservation > return maximization.

Entry Rules (as mirrored)

  1. Quarterly 13F → diff vs prior → NEW and INCREASED become BUYs.
  2. Position sizing: scale % delta to our $100K book.
  3. Trade price = close on quarter-end date.
  4. Skip sub-0.1% positions.

Exit Rules (as mirrored)

  1. EXITED → full SELL.
  2. DECREASED → proportional trim.
  3. No independent stop-losses.

What I DON'T Do

  • No shorts. 13F captures only long US equity.
  • No currency or bond positions.
  • No mid-quarter rotations. By the time the 13F drops (45 days late), he may already be out.
  • No commentary over-ride.

Known Tells

  • 0 → 5%+ in one quarter → High conviction macro call.
  • Position halved → Thesis flipped or risk-off triggered.
  • Gold/precious metals appearing → Fiscal dominance / currency debasement worry.
  • Short-duration tech + macro hedges → Preparing for risk-off without net-short via 13F.

Limitations

  • 45-day lag is brutal for a high-turnover manager.
  • Shorts are invisible.
  • Currency / macro positions invisible.

We accept these limitations. The point is to see how much of his style survives a 45-day lag + long-only filter.

Data Source

  • Primary: WhaleWisdom (manager id 7865)
  • Fallback: --csv
  • SEC EDGAR CIK: 0001536411
  • Import: deno task 13f-import --manager druckenmiller

Current Regime Read

To be filled in after first import.